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Summary
Objective. To evaluate the incidence and risk factors for chronic lung disease in a pop-
ulation of very low birth weight infants.
Methods. In a prospective multicentric trial all very low birth weight infants (< 1500 g)
accepted in 36 Italian Neonatal Intensive care units were studied from February 89 to
January 99. For each patient were recorded maternal history, perinatal events, respira-
tory disease, infections, patent ductus arteriosus, retinopathy of prematurity, intraven-
tricular haemorrhage and final outcome. Logistic regression analysis was performed in
a multivariate assessment of risk factors for chronic lung disease.
Results. In the study were included 1634 patients: 1387 infants survived beyond 36
weeks and 6.9% of them still oxygen dependent.
The incidence of chronic lung disease was higher among babies with a gestational age
of < 28 weeks and weight ≤ 1000 g. The multivariate analysis showed that low birth
weight, respiratory distress syndrome, persistent ductus arteriosus and sepsis were the
main risk factors.
Conclusions. In our study the incidence of chronic lung disease was relatively low
Riassunto
Obiettivo. Valutare l’incidenza ed i fattori di rischio per malattia polmonare cronica in
una popolazione di neonati con peso alla nascita < 1500 g.
Materiali e metodi. In uno studio prospettico multicentrico sono stati considerati tutti i
pazienti con peso < 1500 g ricoverati presso 36 Terapie Intensive Neonatali tra Febbraio
1998 e Gennaio 1999; per ogni paziente erano riferiti i dati perinatali, l’anamnesi oste-
trica, la patologia respiratoria, la presenza di complicanze cliniche e la prognosi. È stata
eseguita un’analisi di regressione logistica per valutare i fattori predittivi la malattia pol-
monare cronica.
Risultati. Sono stati studiati complessivamente 1634 pazienti: 1387 pazienti sopravvive-
vano oltre le 36 settimane di età gestazionale ed il 6,9% di questi sviluppava una malat-
tia polmonare cronica. I pazienti di età gestazionale < 28 e peso ≤ 1000 g ne erano più
frequentemente affetti.
Risultano fattori di rischio per malattia polmonare cronica: il basso peso, la malattia del-
le membrane ialine, il dotto di Botallo pervio e la sepsi.
Conclusione. L’incidenza della malattia polmonare cronica è risultata modesta: ciò è pro-
babilmente imputabile all’esigua percentuale di soggetti con peso ed età gestazionale
estremamente bassi inclusi nello studio ed alla loro elevata mortalità prima delle 36 set-
timane post-concezionali. I dati sono inoltre difficilmente confrontabili con i lavori pub-
blicati per i diversi “target di ossigenazione” valutati, per l’eterogeneità dei pesi e per le
differenti definizioni di malattia polmonare cronica adottate.
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Introduction
CLD (Chronic lung Disease) is one of the most difficult
complications of prematurity: surfactant and the con-
tinuous development of less aggressive ventilatory
techniques has recently improved the course of the dis-
ease but not the percentage of affected infants 1-3.
The incidence of CLD is increasing together with the
increment of ELBW (extremely low birth weight) ba-
bies, as the more premature they are the longer is their
oxygen dependency 4.
The sudden interruption of pulmonary development in-
duced by premature delivery plays a crucial role in the
pathogenesis of the disease 5, which could be in part
worsened by repeated courses of prenatal steroids. If on
the one hand these drugs are known to enhance lung
maturity and improve infant survival, on the other hand
they interfere negatively with early pulmonary and
brain development 6-8.
Immediately after birth, other risk factors – mainly de-
pending on each NICU’s (Neonatal Intensive Care
Unit) management of ventilation, nutrition, fluid in-
takes, etc. – interfere with the occurrence of various de-
grees of CLD.
Like other worldwide initiatives 9-17, the Italian Neona-
tal Pneumology Group comprises a volunteer group of
NICUs established to perform collaborative clinical re-
search in this field. The aim of the study was to evalu-
ate the incidence of CLD among a population of
VLBW infants in Italy and to estimate the degree of as-
sociation between CLD and some of the clinical vari-
ables potentially related to the event.
Patients and methods
The network for the study on CLD comprised 38
NICUs from twelve different Italian regions (23 in the
North, 5 in the Centre, 10 in the South).
The study population included all VLBW infants ad-
mitted to the 38 NICUs during 12 consecutive months
(February 1998-January 1999): 8 NICUs were in Uni-
versity hospitals and 30 in General hospitals. The sur-
vey was conducted by the same individual(s)/doctor(s)
within each unit for the entire study period, using pre-
tested standardised data form and instructions previ-
ously set up by all participants. The Co-ordinating Cen-
tre reviewed the completed forms to ensure completion
and internal consistency. A computer programme was
employed to validate the intrinsic consistency of the
data through crosschecks of dates, diagnoses and man-
agement.
Clinical information recorded for each infant was as
follows:
• name, date, place of birth, GA (gestational age)
(calculated by ultrasound scan or Dubowitz assess-
ment);
• SGA (small for gestational age), defined as birth
weight below the 10th percentile for each GA and
adjusted for sex according to national growth charts
18;
• maternal pre-eclampsia, defined as the presence of
hypertension and proteinuria;
• PPROM (preterm premature rupture of the mem-
branes), if rupture occurred 24 hours before deliv-
ery;
• prenatal infections were diagnosed in the presence
of maternal fever with leucocytosis during labour
and positive vaginal swabs;
• antenatal steroid therapy, defined as maternal
bethametasone therapy – was considered completed
only after two doses of betamethasone (12 mg/day)
24 hours before delivery;
• CRIB score was used to assess the clinical severity
of infants admitted to the NICU 19;
• RDS (Respiratory Distress Syndrome) was diagnosed
from standard clinical signs and chest X-rays 20;
• type and duration of IPPV (Intermittent Positive
Pressure ventilation) and HFOV (High frequency
Oscillatory ventilation), alone or combined, were
recorded;
• CPAP (Continuous Positive Pressure) referred only
to NCPAP (Nasal Continuous Positive Pressure)
therapy used without previous mechanical ventila-
tion;
• Surfactant (CUROSURF®) therapy, doses and time
of administration were recorded;
• CLD, the primary outcome of the study, was de-
fined as being oxygen dependent at 28 days of life
and receiving supplemental oxygen at 36 weeks of
corrected age to maintain SaO2 ≥ 92%;
• PDA (Patent Ductus Arteriosus) diagnosed by typi-
cal clinical, radiological and echocardiographic
findings, was considered when receiving pharmaco-
logical treatment to facilitate ductal closure or sur-
gical legation;
• Sepsis was defined in the presence of positive blood
cultures or clinical signs of deterioration due to gen-
eralized infection plus significant laboratory studies
(anomalies of white cell count and I/T neutrophil ra-
tio, increase in C reactive protein);
• NEC (Necrotizing enterocolitis) was diagnosed, ac-
cording to the criteria of Bell et al. 21, if there was
blood in the stools and pneumatosis intestinalis on
abdominal X-rays;
• IVH (Intraventricular haemorrhage) diagnosed by
serial ultrasound scans of the brain was classified
according to Volpe 22 and taken into consideration if
> II;
• ROP (Retinopathy of Prematurity) was evaluated
using the International Classification of Retinopa-
thy in Prematurity 23 and taken into consideration if
> II;
• Major (life-threatening) malformations were diag-
nosed by clinical signs or instrumentally.
Data analysis
Data management and analyses were carried out using
the EPI6 software package (Centres for Disease Con-
trol and Prevention, Atlanta; GA).
Continuous measures were compared using t-test,
whereas quantitative estimates of the effects of various
covariates such as demographic variables and patho-
logical events were obtained using OR and 95% CI.
The test of statistical significance for contingency ta-
bles was based on the usual χ2 value comparing the ob-
served and expected numbers of events. Where appro-
priate, potential confounding effects were controlled by
stratification and the Mantel-Haenzel procedure.
Logistic regression analysis was performed for the pri-
mary outcome measure (CLD) to determine which
were the statistically significant predictors of the dis-
ease, using SAS statistical software on a 6410 VAX
computer. The stepwise selection procedure was used
to define the best model fitting the data, including vari-
ables for which the p-value was less than 0.25. All tests
were considered statistically significant at a value of p
< 0.05.
Results
A total of 1691 live infants weighing ≤ 1,500 g were
admitted to the 38 NICUs during the one-year study pe-
riod (Tab. I). Each centre treated between 16 and 99
VLBW infants, with a median of 58 infants. Mean
birth-weight of 1,634 infants was 1123 ± 277 g, while
mean GA was 29.6 ± 3.0 weeks. The overall mortality
was 14.3% (234/1634) and among the babies weighing
≤ 1,000 g and ≤ 750 g it was respectively 37%
(199/537) and 56% (122/218).
A total of 96 (5.8%) babies met the definition of CLD;
the incidence of CLD among VLBW infants surviving
at 36 weeks of GA was 6.9% but 19.2% of the whole
study population died or was oxygen-dependent at 36
weeks of corrected age (Fig. 1). The 1387 infants sur-
viving beyond 36 weeks of corrected age, constituted
the study population; the demographic variables and
the clinical conditions of the infants by CLD presence
are shown in Table II. Among this cohort of 1,387
VLBW infants, CLD babies had lower birth weight and
GA, and there was no significant difference if they
were growth retarded foetuses (32.3% vs. 30.9%);
males were 59.4% and a high percentage of both
groups were inborn. The incidence of maternal pre-
eclampsia and PPROM was not remarkable. As many
as 71.9% of babies with CLD were born by Caesarean
section, while multiple deliveries were more often in
the group of the non-oxygen dependent infants. Mater-
nal fever and positive vaginal swabs were not consid-
ered because of data inconsistency. Antenatal steroids
were given to the CLD group in 59.4% vs. 55.4% of the
comparison group. In the CLD group CRIB score was
much higher (p-value 0.0000) than the Apgar score.
The bivariate analysis of illness, postnatal interven-
tions and clinical complications according to the pres-
ence of CLD are shown in Table II.
RDS was the main respiratory illness and was of course
prevalent among CLD babies; as a consequence, sur-
factant therapy was performed in 82.3% of babies with
CLD vs. 36.3% of the others. Mechanical ventilation
was needed in 100% vs. 44.6%. Mean ventilation time
of the CLD infants was 27.5 days (range 0.6-101)
against only 2.73 days (range 0.04-30) in the non CLD
group. None of the affected babies was treated exclu-
sively with NCPAP, while 281/1291 (21.7%) of the
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Tab. I. General data of VLBWi.
VLBWi (n) 1691 (1634)
Birth weight(g) 1123 ± 277
Gestational age (w) 29.6 ± 3
SGA 29.9%
Female 52.2%
Inborn 81%
Caesarean delivery 76.3%
Apgar score 1 minute ≤ 3 26.8%
Apgar score 5 minute ≤ 5 9.9%
CRIB SCORE 3.5 ± 4,2
Antenatal steroids 52%
Multiple gestation 15.65
Placenta previa 3.7%
Preeclampsia 19.2%
HELP syndrome 3%
Chorionamnionitis 1.2%
PPROM 15%
Oligoanidramnios 3.9%
Positive vaginal swabs Incomplited data
Fever during labour Incomplited data
Maternal leucocytosis Incomplited data
Fetal distress 11.6%
Fetal growth retardation 26%
Data are reported as mean (± SD)
comparison group did not need to be intubated and
were on NCPAP for a short period of time. HFO as first
intention was very seldom utilised, (only 14 infants).
HFO as a rescue therapy was performed in 83 patients,
53 of whom (63.8%) did not develop CLD. Postnatal
steroids were used in 67.7% of CLD vs. 13.6% of the
comparison group. The overall incidence of complica-
tions was much higher in the oxygen dependent group.
PDA required pharmacological treatment or surgical
legation in 46.9% of the affected babies vs. 14.1% of
the others (p = 0.0000), sepsis occurred in 65.6% of
CLD babies vs. 15.0% (p = 0.0000), IVH > II was 26%
vs. 7.4% (p = 0.0000), and ROP was 21.8% vs. 1.2% (p
= 0.0000). NEC 8.3% vs. 3.2% (p = 0.0081). Deaths af-
ter 36 weeks corrected age occurred mainly in the
group of affected babies (14/96 vs. 1/1291; p = 0.0000).
Hospitalisation time was almost double if compared to
the control group 119.9 ± 72.8 days in the CLD group
vs. 56.3 ± 28.5 days in the comparison group (p =
0.0000).
The analysis of the data demonstrated that CLD occurs
more frequently in babies < 28 GA (21.5% vs. 4.2%)
and ≤ 1000 g of BW (19.8% vs. 2.76%) The percentage
of patients with CLD according to GA and BW is
shown in Figure 2. In particular, 50% of the infants ≤
25 weeks GA and weighing < 750 g were CLD, while
the percentage was 32% if their weight was between
751 and 1,000 g. The incidence of CLD among infants
born at 26-27 weeks GA weighing < 750 g was 37% but
if their weight was comprised between 751 and 1,000 g
the percentage dropped to 12.3%. Babies of older GA
(≥ 28) are prone to the disease especially when they are
growth retarded and usually when their birth weight is
below 1,000 g (13.4% vs. 2.6%).
The multivariate analysis predicting CLD (Tab. III) per
100 g of weight decrement shows that, besides low
birth weight (OR 1.62 -CI: 1.44-1.83) and RDS (OR
6.58- CI: 2.82-15.40), PDA and sepsis were the main
risk factors with an OR respectively of 2.82 (CI: 1.57-
5.17) and 3.01 (CI: 1.97-4.59).
Discussion
CLD is a typical lung disease affecting babies born
very prematurely, less than 28 weeks GA, weighing
less than 1,000 g and more frequently males 24-26. To
these risk factors already well known in the literature,
there are some others mainly due to the long periods of
care in NICU: they include the need for prolonged me-
chanical ventilation that leads to inflammatory cascade,
the development of sepsis and often patency of the duc-
tus arteriosus 27-29.
The occurrence of CLD therefore seems to be more re-
lated to later events than to the initial respiratory dis-
ease 30. In our study population the group of ELBW
A. CAVAZZA
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Fig. 1. Distribution of study population (VLBW i ≤ 1,500 g).
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Fig. 2. Percentage of patients with CLD according to gestational age and birth weight.
Tab. II. Bivariate analysis of demographic, prenatal and perinatal characteristics, illness, postnatal interventions and clinical com-
plications according to the presence of CLD.
CLD No CLD p-value
(n = 96) (n = 1291)
Birth weight (g) 899 (± 255.7) 1199 (± 226.1) 0.0000
Gestational age (wk) 27.7 (± 2.5) 30.4 (± 2.6) 0.0000
Small for Gestational Age 31 (32.3%) 399 (30.9%) 0.7771
Gender (% male) 57 (59.4%) 594 (46.1%) 0.0118
Inborn (%) 80 (83.3%) 1063 (82.3%) 0.8051
Maternal pre-eclampsia 17 (17.7%) 288 (22.5%) 0.2773
Antenatal Steroids (%) 57 (59.4%) 713 (55.4%) 0.4495
PROM (%) 15 (15.6%) 186 (14.4%) 0.7484
Caesarean section 69 (71.9%) 1047 (81.1%) 0.0278
Multiple delivery 12 (12.5%) 241 (18.7%) 0.1311
Apgar score ≤ 3 at 1 min 1.7 (± 0.9) 2.1 (± 0.9) 0.0379
< 6 at 5 min 2.1 (± 0.9) 4.1 (± 1.3) 0.7213
CRIB score 6.2 (± 3.7) 2.3 (± 2.6) 0.0000
RDS (%) 93 (96.9%) 844 (68.5%) 0.0000
VMC (%) 100 (100%) 575 (44.6%) 0.0000
Surfactant (%) 69 (82.3%) 393 (36.3%) 0.0000
Postnatal steroids (%) 65 (67.7%) 175 (13.6%) 0.0000
PDA (%) 45 (46.9%) 182 (14.1%) 0.0000
NEC (%) 8 (8.3%) 41 (3.2%) 0.0081
IVH > II (%) 25 (26%) 93 (7.4%) 0.0000
SEPSIS (%) 63 (65.6%) 194 (15.0%) 0.0000
ROP 21 (21.8%) 15 (1.2%) 0.0000
Deaths (n) 14 (14.6%) 1 (0.08%) 0.0000
Length of hospitalisation (days) 119.9 (± 72.8) 56.3 (± 28.5) 0.0000
Mean (± SD)
represented 33% of the whole sample; outborns were
only 19%, probably because in our country deliveries
at high risk are performed in 3rd level centres, particu-
larly in the north, with a high-density population and
with many NICUs close to one another. The use of an-
tenatal steroids reached an average of 52% (min 27%
max 75%) and it was 59% in the CLD group. This ob-
servation simply indicates that prophylaxis is more
common in high-risk pregnancies. From the literature it
seems that their beneficial effect on the lungs does not
alter the overall incidence of CLD; the administration
of lung surfactant to a wide number of patients and the
less aggressive ventilation now adopted in many inten-
sive care units, could mask the positive impact of ante-
natal steroids. This hypothesis is supported, according
to some authors, by the enhanced number of survivors
between the VLBW infants, compared to a concomitant
lack of decline in the CLD group 31 32.
Twin pregnancies and PPROM did not interfere signifi-
cantly with the incidence of CLD (Tab. I). Prenatal in-
fections diagnosed by the occurrence of maternal fever,
leucocytosis 24 hours before delivery and positive vagi-
nal swabs, all well known high risk factors for the de-
velopment of chronic lung disease were unfortunately
underestimated in our study. This was due to a lack of
data transmission between the obstetric and the neonato-
logic teams. Chorioamnionitis is known to enhance lung
maturation, but at the same time it is responsible for the
onset of severe lung inflammation that predisposes to the
occurrence of chronic lung damage 33-35. SGA infants
represented almost 30% of our study population and
the percentage of those who developed CLD did not
differ significantly from the non CLD group; stratify-
ing for birth weight we were able to observe that the
babies affected by CLD mostly weighed less that 1,000
g, implying that infants born over 28 weeks GA were
prone to the disease mainly if they were growth re-
stricted (Fig. 2). This observation is in accord with that
of Tyson who noticed that nowadays there is a higher
survival rate of intra uterine growth retarded foetuses,
born more prematurely and more often affected by
chronic lung disease. This data is evident if a special
subgroup is considered, i.e., those weighing < 1,000 g
born from mothers with pre-eclampsia 36.
The CRIB score was significantly higher in CLD ba-
bies, reflecting a worse clinical condition in the first 12
hours of life and the use of high FiO2 at birth. Average
time of hospitalisation was almost double for babies af-
fected by CLD; there is an association between length
of hospital stay, low birth weight and low gestational
age although – excluding birth weight and gestational
age – CLD is surely responsible for increasing hospi-
talisation time in these newborns 37. Exogenous surfac-
tant was administered to 82% of the CLD group and to
17.7% of the comparison group as a result of the dif-
ferent degree of respiratory distress or immaturity in
the two groups.
According to the literature the real impact of CLD
among very low birth weight infants is difficult to be
defined. The lack of uniformity in the diagnostic crite-
ria of CLD is responsible for much of the variations in
incidence of the disease between different authors.
Bancalari shows a strikingly different incidence in
CLD among premature infants, according to various
definitions (5.9% if oxygen is administered during the
first 28 days of life, 47.1% if oxygen is administered
for ≥ 28 days during hospitalisation, 25% if oxygen is
administered at 36 weeks CA); that is why CLD in the
VLBW newborns, as reported by the recent literature,
ranges between 4% to 35% 3. In our study CLD at 36
weeks GA occurred in only 5.8% of the whole popula-
tion with an overall mortality rate of 13.4% before 36
weeks CA. Surely the incidence of mortality for this
population influences the incidence of the pathology it-
self; as a matter of fact in our study, analysing the com-
bined outcome of CLD + death, the percentage rises to
19.2%.
Obstetric management in the delivery room, resuscita-
tion at birth, mechanical ventilation, with the vast vari-
ety of different ventilators and ventilating strategies
could be some of the reasons why the results of the out-
come CLD can be so different 38-43.
In Northern Europe, where VLBW infants are mainly as-
sisted by NCPAP, instead of IPPV, the percentage of ba-
bies with CLD is relatively lower: 12.8% in Norway 10,
13% in Finland 13, 14% in Sweden 12. This data is not
only due to ethnic differences or social problems, but
also probably to more gentle ventilation with a less ag-
gressive approach to the patient, starting from the de-
livery room. Van Marter compared two Intensive Care
Units with the same mortality rate and found marked
differences for what concerns the incidence of CLD. In
Boston it is 22% while at the “Babies” in N.Y. City it is
4%. The smooth resuscitation at birth and the wider and
more precocious use of NCPAP in the second Unit is
A. CAVAZZA
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Tab. III. Multivariate analysis predicting CLD (n = 1387 VLBW infants).
Factor OR-crude _i OR-adjusted C.I. (95%) p-value
Birth weight, per 100 g
decrease 0.06 1.62 1.44-1.83 0.0000
Gender (male vs. female) 1.77 0.28 1.95 1.12-3.39 0.0187
RDS 21.73 0.43 6.58 2.81-15.40 0.0000
PDAT 7.40 0.30 2.82 1.57-5.17 0.0005
VMC 9.20 0.35 2.29 1.16-4.53 0.0176
SEPSIS 0.22 3.01 1.97-4.59 0.0000
Likelihood Ratio = 282.1002 d.f. = 6; p-value = 0.0000
thought to be the main factor determining the different
pulmonary outcome 44.
The National Italian trial conducted by Rubaltelli 45 in
1998 reports a 5.6% of babies O2 dependent at 28 days
of life, but referred to a population of neonates affect-
ed by RDS and not only VLBW infants; this data can-
not be compared with ours as CLD was defined with
different criteria. We observed that the incidence of
CLD was significantly higher in the neonates ≤ 1,000 g
or < 28 weeks gestational age. In our study, the babies
admitted to the 38 NICUs had similar demographic fac-
tors and among them there was a relatively low number
of very high-risk neonates, weighing less than 1,000 g
(537/1,634) with a high mortality rate of 37%; we pre-
sume that this could have interfered with the incidence
of CLD in our population.
All CLD babies were intubated, while only 38.6% of
the non CLD group underwent artificial ventilation,
confirming the role of artificial ventilation in enhanc-
ing the inflammatory cascade that leads to lung dam-
age. Of our population 67.7% received postnatal
steroid therapy in order to reduce the time of ventila-
tion, but sometimes this therapy was also prescribed to
reduce oxygen dependency after extubation. In the fu-
ture the restriction of this treatment to the most severe
cases will be of the utmost importance to avoid the risk
of worsening a baby’s neurological outcome 46 47.
Different authors observed that oxygen dependency at
36 weeks’ corrected age was not mainly related to peri-
natal factors, but was more likely due to difference in
practice style among NICU’s and to complications oc-
curring later in the first weeks of life 48. In our study pa-
tients were treated according to the different clinical
practice of each NICU, and the level of oxygenation
considered acceptable by the different clinicians was
not standardized.
Mild forms of CLD tend to become more severe if clin-
ical complications occur, mainly in the subgroup of ba-
bies born with extremely low birth weights. In our
study the incidence of ROP, PDA, IVH, NEC and sep-
sis was much higher in the CLD group. Sepsis was the
more frequent complication occurring in 25% of our
babies with CLD, similar to the 21% found in other
studies 26.
The multivariate analysis, stratified by 100 g of weight,
predicting CLD shows that the lowest weights, togeth-
er with the presence of RDS, the persistence of PDA
and the onset of sepsis are the prevalent risk factors.
Once again, as other authors observed, we found that
CLD is related not only to the initial respiratory dis-
tress but particularly to the presence of later clinical
complications.
Conclusions
The incidence of CLD is highly influenced by the dif-
ferent definitions adopted for the disease and by the
different levels of “oxygenation targets” in various
NICUs around the world. The result CLD + death
seems to be a more reliable outcome. Our data show
that a relatively small number, 6.9% of the VLBW in-
fants studied, were diagnosed as CLD, but this percent
rose to 19.2% if CLD + death was considered as out-
come. A more careful resuscitation in the delivery room
and a better choice of ventilatory techniques, in the fu-
ture, will hopefully reduce the total number of CLD ba-
bies. However, the more severe forms of chronic lung
disease, with poor prognosis “quoad valetudinem”, will
only diminish along with a reduction in clinical com-
plications. Nosocomial infections represent the most
serious danger: they are in fact, responsible for the on-
set of sepsis, often severe, that reopens the ductus, and
the long term ventilation resulting in permanent lung
damage. We therefore have to do our best to improve
survival of VLBW infants reducing the clinical compli-
cations that could affect these infants during their first
weeks of life.
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